Skip to main content
Home

Leading research for life changing results

  • Our Role & Impact
    • About HMRI
    • Our Team
    • Research Funded through HMRI
    • Our Foundations
      • HMRI Foundation
      • HMRI Sydney Foundation
      • HCRF
      • HTRF
      • Borne HMRI
    • Awards and Recognition
      • Researcher Awards
      • HMRI Exceptional Service
    • Our Partnerships
    • Governance
    • Careers
    • Contact Us
  • Medical Research
    • Research
    • Researchers
    • Participate In Research
    • Coronavirus (COVID-19)
  • Support HMRI
    • Donate Online
    • Your Impact
    • Ways to Donate
    • Fundraise
    • Bequests
    • Volunteer
    • Company Donors
  • For Researchers
    • HMRI Connect Researcher Intranet
    • Services for Researchers
      • Clinical Trials Unit
      • Bioinformatics & Special Applications Support
      • Clinical Research Design and Statistics
      • Health Research Economists
      • Funding Support
      • Research Study Recruitment
      • Clinical Trials Roadmap
    • Facilities and Equipment for Researchers
    • Register to be a HMRI Researcher
  • Events
    • Upcoming Events
  • News & Articles
  1. Home
  2. Search Results

Search Results

  • All (3) Remove All (3) filter
  • News & Articles (2)
  • Research (1)

Search found 3 items

All
Drug halves breast cancer recurrence in high risk women
Category: News & Articles
Taking the breast cancer drug Anastrozole for five years reduced the chances of postmenopausal women ... a study published in The Lancet today. Taking the breast cancer drug Anastrozole for five years reduced the chances of postmenopausal women ... worldwide at high risk of breast cancer with half being given 1mg of Anastrozole daily and half given a placebo. In the five years of follow ...
Breast Cancer
Category: Research
... breast cancer, breast cancer research, pink ribbon, BRCA1, BRCA2, anastrozole, preventing breast cancer, breast cancer treatments Breast ...
Breast Cancer – Safety in numbers
Category: News & Articles
... undergone chemotherapy.” The IBISII trial aims to determine whether Anastrozole (Arimidex) can be effective in preventing breast cancer. ...
  • Contact us
  • View Research & Diseases
  • News & Articles
  • Site Map
  • Privacy Policy
  • ​
  • HUNTER MEDICAL RESEARCH INSTITUTE ABN 27 081 436 919 | Phone (02) 4042 0000 |  Donation Hotline 1300 993 822
  •  
  • Copyright © Hunter Medical Research Institute 2022
  •  
  • Tata Consultancy Services